Publicaciones en las que colabora con JOSÉ MANUEL BENÍTEZ DEL CASTILLO SÁNCHEZ (19)

2024

  1. Topical Insulin Eye Drops: Stability and Safety of Two Compounded Formulations for Treating Persistent Corneal Epithelial Defects

    Pharmaceutics, Vol. 16, Núm. 5

2023

  1. A novel osmoprotective liposomal formulation from synthetic phospholipids to reduce in vitro hyperosmolar stress in dry eye treatments

    Journal of Liposome Research, Vol. 33, Núm. 2, pp. 117-128

  2. Desarrollo de una formulación antiglaucomatosa tópica a partir de una lágrima artificial

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Long-acting hybrid microemulsion for the simultaneous treatment of glaucoma and ocular surface diseases

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  4. New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost

    Ocular Surface, Vol. 29, pp. 314-330

2022

  1. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  2. Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

    Acta Ophthalmologica, Vol. 100, Núm. 4, pp. e912-e919

  3. Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection

    International Journal of Pharmaceutics, Vol. 623

  4. Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment

    Pharmaceutics, Vol. 14, Núm. 7

2021

  1. Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments

    Experimental Eye Research, Vol. 211

  2. “In vitro” hyperosmolar design in human corneal epithelial cells and inflammation in macrophages: avoiding the use of animals in the screening of ocular surface therapies

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 41-43

2018

  1. Novel Nano-liposome formulation for dry eyes with components similar to the preocular tear film

    Polymers, Vol. 10, Núm. 4

  2. Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment

    Contact Lens and Anterior Eye, Vol. 41, Núm. 1, pp. 93-96

2014

  1. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film

    Investigative Ophthalmology and Visual Science, Vol. 55, Núm. 12, pp. 7839-7847

2012

  1. Recent patents and developments in glaucoma biomarkers

    Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 3, pp. 224-234

2011

  1. Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers

    Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 6, pp. 3548-3556

2010

  1. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: A flow cytometric study

    Cornea, Vol. 29, Núm. 2, pp. 167-171

  2. The effect of preservative-free HP-Guar on dry eye after phacoemulsification: A flow cytometric study

    Eye, Vol. 24, Núm. 8, pp. 1331-1337

2007

  1. Nuevas formulaciones para el tratamiento del ojo seco

    Archivos de la Sociedad Española de Oftalmologia, Vol. 82, Núm. 7, pp. 395-396